244 related articles for article (PubMed ID: 33425095)
1. Upregulation of RAC3 in bladder cancer predicts adverse clinical outcome and increased tumor immune response.
Ou-Yang S; Liu JH; Wang QZ
Int J Clin Exp Pathol; 2020; 13(12):2937-2949. PubMed ID: 33425095
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
Chen L; Lin J; Wen Y; Chen Y; Chen CB
Front Oncol; 2023; 13():1291720. PubMed ID: 38023241
[TBL] [Abstract][Full Text] [Related]
3. A novel focal adhesion-related risk model predicts prognosis of bladder cancer -- a bioinformatic study based on TCGA and GEO database.
Hu J; Wang L; Li L; Wang Y; Bi J
BMC Cancer; 2022 Nov; 22(1):1158. PubMed ID: 36357874
[TBL] [Abstract][Full Text] [Related]
4. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer.
Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T
Front Genet; 2021; 12():696912. PubMed ID: 34512722
[No Abstract] [Full Text] [Related]
5. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
Sun S; Wang Y; Wang J; Bi J
J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
[TBL] [Abstract][Full Text] [Related]
6. High expression of
Lin B; Zhang T; Ye X; Yang H
Oncol Lett; 2020 Sep; 20(3):2840-2854. PubMed ID: 32782602
[TBL] [Abstract][Full Text] [Related]
7. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
Zhang P; Yang Q
Front Genet; 2021; 12():682856. PubMed ID: 34149818
[TBL] [Abstract][Full Text] [Related]
9. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer.
Gao X; Cai J
Front Genet; 2022; 13():865204. PubMed ID: 35571063
[No Abstract] [Full Text] [Related]
11. Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices.
Pan S; Zhan Y; Chen X; Wu B; Liu B
Front Oncol; 2019; 9():613. PubMed ID: 31334127
[No Abstract] [Full Text] [Related]
12. Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer.
Dong B; Liang J; Li D; Song W; Song J; Zhu M; Zhao S; Ma Y; Yang T
Front Mol Biosci; 2021; 8():688298. PubMed ID: 34368227
[No Abstract] [Full Text] [Related]
13. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
Chen R; Jiang M; Hu B; Fu B; Sun T
Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
15. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma.
Zhao K; Gao M; Lin M
Dis Markers; 2022; 2022():3373851. PubMed ID: 36193495
[TBL] [Abstract][Full Text] [Related]
16. HYAL3 as a potential novel marker of BLCA patient prognosis.
Liu JP; Fang YT; Jiang YF; Lin H
BMC Genom Data; 2022 Aug; 23(1):63. PubMed ID: 35945500
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer.
Li H; Zhang Y; Zheng S
Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692
[TBL] [Abstract][Full Text] [Related]
18. P4HB: A novel diagnostic and prognostic biomarker for bladder carcinoma.
Wu Y; Peng Y; Guan B; He A; Yang K; He S; Gong Y; Li X; Zhou L
Oncol Lett; 2021 Feb; 21(2):95. PubMed ID: 33376528
[TBL] [Abstract][Full Text] [Related]
19. Identification of hexosamine biosynthesis pathway as a novel prognostic signature and its correlation with immune infiltration in bladder cancer.
Cui Y; Feng H; Liu J; Wu J; Zhu R; Huang R; Yan J
Front Mol Biosci; 2022; 9():1009168. PubMed ID: 36158580
[No Abstract] [Full Text] [Related]
20. A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer.
Cai Y; Cheng Y; Wang Z; Li L; Qian Z; Xia W; Yu W
BMC Cancer; 2023 Aug; 23(1):725. PubMed ID: 37543645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
